Carregant...
Agomelatine for the Treatment of Generalized Anxiety Disorder: A Meta-Analysis
OBJECTIVE: Despite multiple drugs available, a large proportion of patients with generalized anxiety disorder (GAD) do not show adequate response and remission. Thus, additional novel pharmacological agents are needed to increase treatment option for GAD. We aimed to investigate efficacy and safety...
Guardat en:
| Publicat a: | Clin Psychopharmacol Neurosci |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Korean College of Neuropsychopharmacology
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7383014/ https://ncbi.nlm.nih.gov/pubmed/32702221 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9758/cpn.2020.18.3.423 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|